ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,524.40
      1.06%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      -2.20%
      Bitcoin
      67,887.84
      3.19%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Vaccinex Inc (VCNX)

      7. Vaccinex Inc (VCNX) News

      VCNX

      Vaccinex (VCNX)

      Vaccinex Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:VCNX
      DateTimeSourceHeadlineSymbolCompany
      07/17/20248:00AMGlobeNewswire Inc.Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease at the Alzheimer’s Association International Conference, Philadelphia, July 31, 2024NASDAQ:VCNXVaccinex Inc
      07/08/20244:16PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VCNXVaccinex Inc
      07/08/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VCNXVaccinex Inc
      06/06/20248:36AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
      06/06/20248:30AMGlobeNewswire Inc.Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s DiseaseNASDAQ:VCNXVaccinex Inc
      05/31/20244:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCNXVaccinex Inc
      05/15/20246:00PMGlobeNewswire Inc.Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:VCNXVaccinex Inc
      05/15/20245:24PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VCNXVaccinex Inc
      05/14/20244:36PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:VCNXVaccinex Inc
      05/14/20244:35PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:VCNXVaccinex Inc
      05/14/20244:35PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:VCNXVaccinex Inc
      05/14/20244:34PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:VCNXVaccinex Inc
      05/14/20244:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCNXVaccinex Inc
      05/14/20244:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCNXVaccinex Inc
      05/14/20244:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCNXVaccinex Inc
      05/14/20244:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCNXVaccinex Inc
      05/13/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VCNXVaccinex Inc
      05/10/202412:33PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VCNXVaccinex Inc
      05/09/20245:08PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VCNXVaccinex Inc
      05/09/20244:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
      05/08/202412:29PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:VCNXVaccinex Inc
      04/02/20248:30AMGlobeNewswire Inc.Vaccinex Reports 2023 Financial Results and Provides Corporate UpdateNASDAQ:VCNXVaccinex Inc
      03/27/20248:30AMGlobeNewswire Inc.Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:VCNXVaccinex Inc
      03/04/20244:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
      02/21/202410:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
      02/21/20248:00AMGlobeNewswire Inc.Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus TechnologyNASDAQ:VCNXVaccinex Inc
      02/15/20248:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
      02/15/20248:00AMGlobeNewswire Inc.Vaccinex, Inc. Announces Reverse Stock SplitNASDAQ:VCNXVaccinex Inc
      02/13/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
      02/13/20244:15PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:VCNXVaccinex Inc
       Showing the most relevant articles for your search:NASDAQ:VCNX